iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Nifty Pharma trades higher; Strides Pharma, Granules India emerge top gainers

11 Jan 2022 , 12:00 PM

Stock market report with bull and bear

Nifty Pharma stocks were trading higher to go with bullish markets on Tuesday. The Index was placed better in the morning gaining over 0.6% but trimmed gains in the mid-day trading session.

Strides Pharma and Granules India led the gains while Lupin, Divis Lab, and Sun Pharma added to the gains. Gland Pharma and Auro Pharma were under extreme pressure.


Sensex rose 200 points, Nifty near 18,050 after volatile trade. IT stocks trade firm ahead of key earnings tomorrow. Global Indices were mixed amid rising Omicron cases and likely US Fed rate hikes.

At around 12.00 noon, BSE Sensex was trading at 60,579.77 up 184.14 points or 0.30% and Nifty50 at 18,048.45 up 45.15 points or 0.25%. Nifty Pharma was trading at 13,908.45 up 49.50 points or 0.36%, touching a high of 13,974.60 and low of 13,842.50 during intraday trade on Tuesday.

Strides Pharma rose 1.72% at Rs459.50 per piece to lead the gains while Granules India was also 1.7% higher at Rs332.30 per piece. Lupin gained 1.35% at Rs951.00 per piece. Divis Lab was 1.23% higher at Rs4,520.70 per piece. Sun Pharma also lifted performance at Rs833.75 per piece, up 0.85%. 

Gland Pharma dragged 2.55% at Rs3,764.00 per piece to emerge the top loser. Auro Pharma was also 2.1% lower at Rs721.75 per piece.

Related Tags

  • Aurobindo Pharma share price
  • Biocon share price
  • Cadila Healthcare share price
  • Cipla share price
  • Coronavirus vaccine
  • Covid-19 new cases
  • Covid-19 vaccine
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.